Skip to main content
Premium Trial:

Request an Annual Quote

Hybrigenics Acquires Dualsystems Biotech's Yeast Two-Hybrid Business

NEW YORK (GenomeWeb News) – Hybrigenics has acquired the yeast two-hybrid assets of Swiss biotech firm Dualsystems Biotech.

The acquisition provides Hybrigenic Services, a subsidiary of Paris-based biopharma firm Hybrigenics that specializes in protein-protein interaction work, with exclusive ownership of patented yeast two-hybrid screening technology for membrane proteins. The deal will expand the company's commercial reach in German-speaking territories, Eastern Europe, and China, it said.

Dualsystems Biotech's yeast two-hybrid operation "is both a business and technology opportunity which fits precisely well with our current expert leadership position in the field of functional proteomics," Hybrigenics CEO Remi Delansorne said in a statement.

Financial terms of the deal were not disclosed. Hybrigenics noted, however, that it would not involve the issuance of any of its shares.